Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Capital Work in Progress

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Capital Work in Progress --₹26 Cr₹6.20 Cr₹0.25 Cr

What is the latest Capital Work in Progress ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Capital Work in Progress ratio of SYNCOM FORMULATIONS (INDIA) is - based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025-
Mar2024-
Mar2023₹26 Cr
Mar2022₹6.20 Cr
Mar2017₹0.25 Cr

How is Capital Work in Progress of SYNCOM FORMULATIONS (INDIA) Trending?

Years Capital Work in Progress % Change
Mar2025 -
0
Mar2024 -
-100.00
Mar2023 ₹26 Cr
312.61
Mar2022 ₹6.20 Cr
2,420.73
Mar2017 ₹0.25 Cr -

Compare Capital Work in Progress of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,200.4 Cr -6.2% 7.5% -20.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,217.0 Cr 0.4% 5.6% 1.8% Stock Analytics
DIVIS LABORATORIES ₹166,047.0 Cr -0.5% 3.3% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,872.0 Cr 4.5% 10% 41.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,454.0 Cr 1.5% 4.8% 9.1% Stock Analytics
CIPLA ₹107,136.0 Cr -1.7% 1% -10.5% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-6.2%

7.5%

-20.1%

SENSEX

-1.5%

0.8%

8.2%


You may also like the below Video Courses